New Data Show Efficacy, Safety and Tolerability of Xeplion(R) in Patients with Schizophrenia at Various Stages of the Disease

PALMFlexS study better reflects Xeplion® use in everyday clinical practice compared to previous clinical trials BEERSE, Belgium--(Healthcare Sales & Marketing Network)--Janssen Pharmaceutica NV has announced results of the PALMFlexS study during Th... BiopharmaceuticalsJanssen Pharmaceutica, Xeplion, paliperidone, Schizophrenia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news